Physician profile
Niranjan Rao
NPI 1851350615
$1,529.50
in general payments reported to CMS, 2019-2025
11 companies · $822 in 2025
The $822 reported for 2025 was more than what 86% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.89 · 2020: $148 · 2021: $240 · 2024: $292 · 2025: $822.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $878 · Travel and Lodging: $236.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $877.52 |
| Travel and Lodging | $236.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $372.31 | 2020-2021 | |
| Siemens Medical Solutions USA, INC. | $345.44 | 2024-2025 | Artis Icono Biplane, Eclipse Treatment Planning System For External Beam Radiation Therapy, Truebeam |
| Kestra Medical Technology Services, INC. | $247.89 | 2025 | Assure Wcd |
| Penumbra, INC. | $218.51 | 2025 | Indigo System |
| Boston Scientific Corporation | $122.76 | 2025 | General - Vascular Intervention |
| Abiomed | $79.53 | 2025 | |
| Cvrx, INC. | $53.49 | 2025 | Barostim Neo System |
| Medtronic Vascular, INC. | $27.89 | 2019 | |
| Convatec INC. | $27.17 | 2024 | |
| Integra Lifesciences Corporation | $18.73 | 2024 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Medtronic, INC. | $15.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Niranjan Rao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.